IMMUNIC, INC. 8-K

What Happened Immunic, Inc. announced on July 14, 2026 that it made an updated corporate/investor presentation available on its website and filed that presentation as Exhibit 99.1 to a Current Report on Form 8-K. The disclosure was made under Item 7.01 (Regulation FD disclosure) and the presentation is incorporated by reference into the filing.

Key Details

• Presentation dated July 14, 2026 was posted on Immunic’s website and attached to the 8-K as Exhibit 99.1.
• The 8-K was filed on July 14, 2026 under Item 7.01 (Regulation FD Disclosure).
• The presentation is incorporated by reference into the Form 8-K filing.

Why It Matters This filing ensures Immunic’s updated presentation was publicly and simultaneously disclosed in compliance with Regulation FD, giving all investors access to the same company information. Investors should review the posted presentation (on Immunic’s website or via the SEC exhibit) for any updates to the company’s strategy, clinical pipeline, or other investor information that could be material to investment decisions.